“Prognostic Value of Neutrophil-to-Lymphocyte Ratio in MCRPC Patients Treated With Abiraterone, Enzalutamide and Docetaxel: A Retrospective Single-Center Study”. Archivio Italiano di Urologia e Andrologia (August 7, 2026). Accessed August 12, 2026. https://www.pagepressjournals.org/aiua/article/view/15630.